Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.01.24.577111

The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons

Abstract

Background and PurposeThe mechanistic target of rapamycin (mTOR) signaling pathway is a key regulator of cell growth and metabolism. Its deregulation is implicated in several diseases. The macrolide rapamycin (RAP), a specific inhibitor of mTOR, has immunosuppressive, anti-inflammatory and antiproliferative properties. Recently, we identified tacrolimus, another macrolide immunosuppressant, as a novel activator of TRPM8 ion channels, involved in cold temperature sensing, thermoregulation, tearing and cold pain. We hypothesized that RAP may also have agonist activity on TRPM8. Experimental approachUsing calcium imaging and electrophysiology in transfected HEK293 cells and wildtype or Trpm8 KO mouse DRG neurons, we characterized RAP effects on TRPM8. We also examined the effects of RAP on tearing in mice. Key ResultsMicromolar concentrations of RAP activate rat and mouse TRPM8 directly and potentiate cold-evoked responses. These effects were also observed in human TRPM8. In cultured mouse DRG neurons, RAP evoked an increase in intracellular calcium almost exclusively in cold-sensitive neurons. Responses were drastically blunted in Trpm8 KO mice or by TRPM8 antagonists. Cutaneous cold thermoreceptor endings were also activated by RAP. Topical application of RAP to the eye surface evokes tearing in mice by a TRPM8-dependent mechanism. Conclusion and implicationsThese results identify TRPM8 cationic channels in sensory neurons as novel molecular targets of the immunosuppressant RAP. These findings may help explain some of its therapeutic effects after topical application to the skin and the eye surface. Moreover, RAP could be used as an experimental tool in the clinic to explore cold thermoreceptors. Bullet point summaryWHAT IS ALREADY KNOWN O_LITRPM8 is a polymodal channel involved in cold detection, thermoregulation, tearing and cold pain C_LIO_LITacrolimus, a macrolide immunosupressor, is an agonist of cold-activated TRPM8 channels C_LI WHAT THIS STUDY ADDS O_LIThe macrolide rapamycin also activates directly TRPM8 channels in mouse sensory neurons and human TRPM8 C_LIO_LIRapamycin stimulates tearing in mice in a TRPM8-dependent manner CLINICAL SIGNIFICANCE C_LIO_LIRapamycin, an FDA-approved drug, shows agonist activity on TRPM8 channels C_LIO_LIBeneficial effects of rapamycin and other macrolides on inflammatory ocular disorders may involve TRPM8 activation C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Arcas, J. M., Oudaha, K., Gonzalez, A., Fernandez-Trillo, J., Peralta, F. A., Castro-Marsal, J., Poiraz, S., Taberner, F., Sala, S., de la Pena, E., Gomis, A., Viana, F.. 2024-01-28. The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons. https://doi.org/10.1101/2024.01.24.577111

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

EPHB2 promotes long-range axon extension and its variants cause callosal dysgenesis

The corpus callosum (CC) is the largest fibre tract connecting the cerebral hemispheres, essential for integrating neural activity across large-scale brain networks. Accordingly, abnormal CC development is associated with diverse neurodevelopmental and neuropsychiatric disorders. Callosal projection neurons (CPNs) of the cortex form the CC by extending long-range axons to the contralateral hemisphere; however, the mechanisms that sustain axon elongation over such remarkable distances remain poorly understood. Here we show that variants in the human gene EPHB2, which encodes a tyrosine kinase receptor regulating nervous system development and implicated in neurodevelopmental disorders, cause CC dysgenesis. We characterise variant- specific effects on EPHB2 signalling and demonstrate that variants identified in individuals with distinct CC morphologies differentially alter CPN axon outgrowth and integration in vivo. We further show that EphB2 has a cell-autonomous, ligand-independent function in promoting CPN axon outgrowth by spatially organising actomyosin at axonal growth cones. These findings reveal a previously unrecognised role for EphB2 in promoting long-range axon extension and provide the first evidence that EPHB2 variants cause CC dysgenesis in humans. More broadly, our study links molecular variation in EPHB2 to individualised abnormalities in brain connectivity and provides a framework for understanding how heterogeneous circuit-level phenotypes arise in neurodevelopmental disorders.

neuroscience↗

E2F4 gene therapy reverses established synaptic and cognitive deficits and remodels learning-associated signaling in Alzheimer's disease mice

Alzheimer's disease (AD) causes progressive synaptic dysfunction, neurodegeneration, and cognitive decline, yet strategies capable of reversing established deficits remain limited. Here, we show that neuronal expression of a p38MAPK phosphorylation-resistant human E2F4 variant (hE2F4DN), delivered by adeno-associated virus, restores hippocampal long-term potentiation and memory in homozygous 5xFAD mice after functional impairment is established. Treatment also reduces amyloid-{beta} and phospho-tau pathology and prevents hippocampal neuronal loss. Integrated proteomic and phosphoproteomic analyses reveal remodeling of metabolic, redox, neuroimmune, synaptic-vesicle, and GSK3{beta}-associated signaling pathways. Following contextual fear conditioning, hE2F4DN-treated mice exhibit broader learning-associated synaptic proteomic signatures and distinct phosphoregulatory responses involving synaptic machinery. These findings demonstrate that E2F4 gene therapy can reverse established synaptic and cognitive deficits while preserving neuronal integrity and reshaping molecular responses to learning, identifying E2F4 phosphorylation as a potential therapeutic target for advanced AD states.

neuroscience↗

Complex Spatial and Temporal Organization of Functional Brain Networks

Recent research exploring brain-behavior associations has relied on the language of complex systems to understand how stable behavioral individual differences emerge from brain function. At the same time, advances in neuroimaging have provided greater insight into both the topological and temporal properties of macroscale cortical networks. These new approaches offer a potential avenue for understanding how functional activity in the brain might behave in a manner that aligns with complex-systems interpretations of psychological traits. The present study used resting-state data from the Human Connectome project (N = 994) to explore associations between the spatial and temporal features of functional brain networks. Using an adaptive frequency approach to explore brain function at different timescales together with a family of methods from complex systems theory, we identified patterns of brain state organization reflecting a state-trait continuum, with more stable trait-like dynamics and greater functional coupling between networks in lower frequency oscillations. Additionally, we found evidence of greater coupling across timescales in brain networks associated with higher-order cognition. This research supports interpretations of brain organization as a spatiotemporal hierarchy and provides future avenues for exploring brain-behavior associations from a complex system perspective.

neuroscience↗